Skip to main content
. 2022 Feb 28;12:849376. doi: 10.3389/fonc.2022.849376

Table 1.

Demographics and disease presentation of myeloid neoplasms with DNMT3A (R882 vs. Non-R882) mutations.

DNMT3A R882 (Total = 36) DNMT3A non-R882 (Total = 43) P value*
Average age (Range) 66 (40–91) 72 (47-86) NS
Gender
 Male 21 17 NS
 Female 15 26
Disease at presentation
AML (total 40) 27 (67.5%) 13 (32.5%) 0.0003
MDS (total 28) 7 (25%) 21 (75%) 0.009
MDS/MPN (total 3) 1 (33.5%) 2 (66.5%) NS
MPN (total 8) 1 (12.5%) 7 (87.5%) 0.06

*T-test for age, and Fisher’s exact test for others.

NS, not significant; AML, Acute myeloid leukemia; MDS, Myelodysplastic syndrome; MPN, Myeloproliferative neoplasm.